- Home
- SRZN vs ICAD Comparison
SRZN vs ICAD Comparison
Compare SRZN & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- ICAD
- Stock Information
- Founded
- SRZN 2015
- ICAD 1984
- Country
- SRZN United States
- ICAD United States
- Employees
- SRZN N/A
- ICAD N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- ICAD Medical/Dental Instruments
- Sector
- SRZN Health Care
- ICAD Health Care
- Exchange
- SRZN Nasdaq
- ICAD Nasdaq
- Market Cap
- SRZN 38.1M
- ICAD 40.8M
- IPO Year
- SRZN N/A
- ICAD 1986
- Fundamental
- Price
- SRZN $10.57
- ICAD $1.83
- Analyst Decision
- SRZN
- ICAD
- Analyst Count
- SRZN 0
- ICAD 0
- Target Price
- SRZN N/A
- ICAD N/A
- AVG Volume (30 Days)
- SRZN 49.1K
- ICAD 333.4K
- Earning Date
- SRZN 11-06-2024
- ICAD 11-13-2024
- Dividend Yield
- SRZN N/A
- ICAD N/A
- EPS Growth
- SRZN N/A
- ICAD N/A
- EPS
- SRZN N/A
- ICAD N/A
- Revenue
- SRZN $10,000,000.00
- ICAD $18,940,000.00
- Revenue This Year
- SRZN N/A
- ICAD $10.15
- Revenue Next Year
- SRZN N/A
- ICAD $3.75
- P/E Ratio
- SRZN N/A
- ICAD N/A
- Revenue Growth
- SRZN N/A
- ICAD 10.03
- 52 Week Low
- SRZN $6.00
- ICAD $1.18
- 52 Week High
- SRZN $16.19
- ICAD $2.65
- Technical
- Relative Strength Index (RSI)
- SRZN 54.47
- ICAD 52.11
- Support Level
- SRZN $9.50
- ICAD $1.65
- Resistance Level
- SRZN $11.27
- ICAD $1.86
- Average True Range (ATR)
- SRZN 1.10
- ICAD 0.16
- MACD
- SRZN 0.01
- ICAD -0.00
- Stochastic Oscillator
- SRZN 41.36
- ICAD 36.73
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.